Correction: Leveraging real-world data for safety signal detection and risk management in pre- and post-market settings
Kathleen M. Gavin, Matthew L. Sundermann, Alethea Wieland
Abstract
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOccupational Health and Safety Research · Risk and Safety Analysis · Pharmacovigilance and Adverse Drug Reactions
The reference for [EMA, 2017] was erroneously written as “EMA (2017). Guideline on good pharmacovigilance practices (GVP) module IX–Signal management. Available online at: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-module-ix-signal-management-rev-1_en.pdf.” It should be “European Medicines Agency (2017). Guideline on good pharmacovigilance practices (GVP) module IX–Signal management. Available online at: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-good-pharmacovigilance-practices-gvp-module-ix-signal-management-rev-1_en.pdf”.
The reference for European Medicines Society, 2023 was erroneously written as “European Medicines Society (2023). ICH M14 general principles on plan, design and analysis of pharmacoepidemiological studies that utilize real-world data for safety assessment of medicines - scientific guideline. Available online at: https://www.ema.europa.eu/en/ich-m14-guideline-general-principles-plan-design-analysis-pharmacoepidemiological-studies-utilize-real-world-data-safety-assessment-medicines-scientific-guideline”. It should be “European Medicines Agency (2025). ICH M14 general principles on plan, design and analysis of pharmacoepidemiological studies that utilize real-world data for safety assessment of medicines - scientific guideline. Available online at: https://www.ema.europa.eu/en/ich-m14-guideline-general-principles-plan-design-analysis-pharmacoepidemiological-studies-utilize-real-world-data-safety-assessment-medicines-scientific-guideline”.
The reference for European Medicines Society, 2025 was erroneously written as “European Medicines Society (2025). Data analysis and real world interrogation network (DARWIN EU). Available online at: https://www.ema.europa.eu/en/about-us/how-we-work/data-regulation-big-data-other-sources/real-world-evidence/data-analysis-real-world-interrogation-network-darwin-eu”. It should be “European Medicines Agency (2025). Data analysis and real world interrogation network (DARWIN EU). Available online at: https://www.ema.europa.eu/en/about-us/how-we-work/data-regulation-big-data-other-sources/real-world-evidence/data-analysis-real-world-interrogation-network-darwin-eu”.
The reference for Rosati et al., 2022 was erroneously written as “Rosati, K., Jorgensen, N., Soliz, M., and Evans, B. (2022). HIPAA and common rule compliance in the Sentinel initiative. Sentinel initiative principles and policies”. It should be “Rosati, K., Jorgensen, N., Soliz, M., and Evans, B. (2018). HIPAA and common rule compliance in the Sentinel initiative. Sentinel initiative principles and policies. Available at: https://www.sentinelinitiative.org/sites/default/files/communications/publications-presentations/HIPAA-Common-Rule-Compliance-in-Sentinel-Initiative.pdf”.
The reference for U.S. Food and Drug Administration, 2023a was erroneously written as “U.S. Food and Drug Administration (2023a). Data standards for drug and biological product submissions containing real-world data guidance document. Available online at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-use-real-world-data-and-real-world-evidence-support-regulatory-decision-making-drug”. It should be “U.S. Food and Drug Administration (2023a). Data standards for drug and biological product submissions containing real-world data guidance document. Available online at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/data-standards-drug-and-biological-product-submissions-containing-real-world-data”.
The original article has been updated.